India, EU FTA Talks Said Leading To Loss Of Essential Drug Access
This article was originally published in PharmAsia News
Executive SummaryIndia's free trade agreement being negotiated with the European Union is being criticized in some quarters as leading to much of the population losing access to essential drugs
You may also be interested in...
Indian Pharma Lobby Flays India-EU Trade Talks; Debunks "TRIPS Plus" Provisions On Patent Extensions And Data Protection
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.